国产精品九九99,久久任你操,精选一区二区

FDA Requests COVID-19 Vaccine Label Updates on Heart Risks Moderna The FDA has requested Pfizer/BioNTech and Moderna update COVID-19 vaccine labels to reflect myocarditis and pericarditis risks in males aged 16-25. This update aligns with new FDA vaccine approval guidelines focusing on high-risk groups.
Pfizer's Talzenna Label Bid Faces Setback FDA The FDA’s advisory committee unanimously rejected Pfizer’s proposal to expand Talzenna’s use for prostate cancer patients without HRR mutations, citing insufficient evidence from the TALAPRO-2 trial.
FDA Panel Supports Darzalex for Early Myeloma Darzalex Johnson & Johnson's Darzalex Faspro gains FDA advisory backing as a potential first treatment for high-risk smoldering multiple myeloma, despite concerns over trial design, patient selection, and long-term efficacy.
Montana Allows Drug Sales Post-Phase 1 Without FDA Approval FDA Montana passes groundbreaking legislation allowing in-state sale of drugs after Phase 1 trials without FDA approval, aiming to boost experimental treatments and medical tourism.
Low-Dose IL-2 Boosts ALS Survival When Added to Riluzole Treatment FDA A new study in The Lancet shows that adding low-dose IL-2 to riluzole significantly improves survival and slows disease progression in ALS patients, offering a promising new therapeutic strategy.
FDA Approvals Summary - April 2025 FDA Drug Approvals Discover the FDA's new drug approvals in April 2025, including treatments for IgAN, nasopharyngeal carcinoma, myasthenia gravis, and colorectal cancer. Learn about groundbreaking therapies like Vanrafia, Penpulimab-KCQX, and Imaavy.
Trump Signs Executive Order to Accelerate Domestic Drug Manufacturing FDA On May 5, Trump signed an executive order to simplify regulations and accelerate domestic pharmaceutical manufacturing, aiming to reduce U.S. dependence on foreign drug production.
FDA Drug Rejections (January-April 2025) FDA From January to April 2025, the FDA rejected six new drug applications, citing issues like clinical data, CMC problems, and third-party manufacturing concerns. Learn more about each case.
Single Dose of Baloxavir Cuts Household Flu Transmission by 32%: NEJM Study Roche A NEJM study shows that a single dose of Baloxavir (Tamiflu?) reduces household influenza virus transmission by 32%. Backed by Roche, the findings offer new hope for flu prevention and public health impact.
The Cost of Attacking the Pharmaceutical Industry Trump Trump's policies during his second term have rocked the U.S. scientific community, slashing NIH funding, threatening pharmaceutical innovation, and reshaping the global research landscape amid rising concerns about America's future in science.

< Pre 1 234 5 6 7 8...10 Next >

Articles Archives

Hot Articles

All Categories

Agri & Industry Cosmetic Laboratory Pharmaceutical Food

国产91视频久久,亚洲综合色图在线观看,五月天操逼网,日韩色色AV,青青在线A片,亚洲最大色在线观看,欧美熟妇丝袜诱惑,青青操逼视频,日韩无码操出水